Oncology
Mace Rothenberg, MD
Chief Development Officer and Head of Clinical Development & Medical Affairs, his team secured regulatory
Nashville, TN
Dr. Mace Rothenberg, MD, FACP, is a distinguished medical oncologist with over 40 years of experience in clinical care, drug development, translational research, and oncology leadership. He specializes in medical oncology, having trained at premier institutions and contributed significantly to advancing cancer therapies. His clinical expertise encompasses solid tumor malignancies, particularly breast cancer (HR+/HER2- advanced disease treated with CDK4/6 inhibitors like IBRANCE/palbociclib) and
Credentials
Board Certifications
- Medical Oncology (ABIM)
- Internal Medicine (ABIM)
Education & Training
- National Institutes of Health Clinical Center — Fellowship, Hematology and Medical Oncology, 1985 - 1988
- Vanderbilt University Medical Center — Residency, Internal Medicine, 1982 - 1985
- New York University Grossman School of Medicine — M.D., 1982
- University of Pennsylvania — B.A., magna cum laude, 1978
Peer Recognition
- American Cancer Society — Lane W. Adams Quality of Life Award
- American Society of Clinical Oncology — Statesman Award
- Pfizer — Craig Saxton Lifetime Achievement Award
Clinical Focus
Subspecialties
Precision Oncology & GenomicsMedical Oncology
Conditions & Treatments
Cancer SurvivorshipChemotherapy
Practice Details
Hospital Affiliations
- Vanderbilt University Medical Center
Languages
English